Pfizer secures up to $1.5 billion from Blackstone for obesity drug development

 

Nov 11 (Reuters) – Pfizer said on Wednesday Blackstone would provide up to $1.5 billion through 2028 to help fund the development of its experimental monthly obesity treatment.

(Reporting by Kunal Das in Bengaluru; Editing by Leroy Leo)

Brought to you by www.srnnews.com

Follow Us

WYSL LIVE

UPCOMING SHOWS

Recent Posts

Related Posts: